People · Operator
Named in public records as an officer, director or promoter · active 2011–2023 · Other Health Care, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Spirox, Inc. | — | Other Health Care | Series C | $98.2M | $1.0B | 2015 |
| Mahzi Therapeutics Inc. | — | Biotechnology | Series C | $52.6M | $1.3B | 2021 |
| Ocelot Bio, Inc. | — | Pharmaceuticals | Series B | $39.0M | $31.0M | 2021 |
| Kythera Biopharmaceuticals Inc | — | Pharmaceuticals | Series B | $37.4M | $1.3B | 2011 |
| Biolux Research Holdings, Inc. | — | Other Health Care | Series A | $12.7M | $256.3M | 2019 |
| XCaliber Biotechnology, Inc. | — | Biotechnology | Seed | $1.1M | $48.8M | 2020 |
Camille Samuels at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Camille Samuels on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Nelsen | 1 | 22 |
| Jack Nielsen | 1 | 13 |
| Duke Rohlen | 1 | 10 |
| Aftab Kherani | 1 | 9 |
| Doug Koo | 1 | 8 |
| David Schnell | 1 | 7 |
| Anthony J. Natale | 1 | 5 |
| STACY ENXING SENG | 1 | 5 |
| David Thrower | 1 | 5 |
| Shalini Sharp | 1 | 4 |
| Hironori Hozoji | 1 | 4 |
| Joseph Turner | 1 | 4 |
| Anthony Natale | 1 | 4 |
| Geoffrey Harris | 1 | 4 |
| Dennis Fenton | 1 | 4 |
| Donald Santel | 1 | 4 |
| Marten Steen | 1 | 3 |
| Francois Kress | 1 | 3 |
| Nathaniel David | 1 | 3 |
| Keith Leonard | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.